Skip to record
ExecutivesAnna Protopapas

Executive record

Anna Protopapas

Director at Nuvalent, Inc.

Follow record
More
Challenge a Claim

Alpha ID: alpha:person:anna-protopapasVersion: public-0As of: 2026-10-01

Not yet claimed9 published Claims4 sources
  • Director

Leadership, in context.

Connect capital, control, accountability, and evidence.

Published Claims9Within this recordEvidence sources4Inspect provenance and dates

Explore the record

ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.

Key Claims

Biography

Anna Protopapas has served as Chairperson of Nuvalent's board since March 2022 and served as President and CEO of Mersana Therapeutics from March 2015 to September 2023. She previously held senior roles at Takeda Pharmaceutical, including President of Millennium Pharmaceuticals and EVP of Global Business Development. She holds a B.S. from Princeton, an M.S. from MIT, and an M.B.A. from Stanford Graduate School of Business.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.